Craneware PLC
F:3X6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (16.3), the stock would be worth €4.19 (76% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 67.4 | €17.3 |
0%
|
| 3-Year Average | 16.3 | €4.19 |
-76%
|
| 5-Year Average | 23.7 | €6.09 |
-65%
|
| Industry Average | 0 | €0.01 |
-100%
|
| Country Average | 0 | €0.01 |
-100%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Craneware PLC
F:3X6
|
540.4m EUR | 67.4 | 30.8 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
27.5B USD | 14 | 29.3 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.9B AUD | 112.5 | 62.2 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 13.9 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | 63.2 | 96.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
5B USD | 20.1 | 43.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 11.8 | 18.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 61.3 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.6B CNY | 36.8 | -60.4 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.7B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 2 105.8 |
Other Multiples
Craneware PLC
Glance View
Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance. Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.